Close



Apr 22, 2024 04:31PM
Apr 22, 2024 04:30PM
Mar 19, 2024 04:10PM
Jan 4, 2024 07:06AM
Jan 4, 2024 07:00AM
Dec 11, 2023 03:52AM
Dec 10, 2023 12:00PM Adicet Bio Highlights ADI-001 Expansion, Persistence and Pharmacodynamic Profile from Ongoing Phase 1 Study at the 65th American Society of Hematology (ASH) Annual Meeting
Nov 8, 2023 04:10PM
Aug 9, 2023 04:15PM
Jul 11, 2023 08:31AM
Jul 11, 2023 08:30AM
Jun 26, 2023 04:00PM
Jun 26, 2023 04:00PM
Jun 1, 2023 05:16AM JPMorgan Downgrades Adicet Bio Inc. (ACET) to Neutral
May 18, 2023 06:00AM
May 18, 2023 06:00AM
May 9, 2023 04:10PM
Mar 15, 2023 04:01PM
Dec 12, 2022 10:05AM
Dec 12, 2022 07:47AM
Dec 10, 2022 10:00AM Adicet Bio Reports Positive Data from Ongoing ADI-001 Phase 1 Trial in Patients with Relapsed or Refractory Aggressive B-Cell Non-Hodgkin’s Lymphoma (NHL)
Nov 29, 2022 07:00AM
Nov 7, 2022 08:00AM
Nov 3, 2022 09:03AM
Nov 3, 2022 09:00AM
Aug 10, 2022 07:00AM
Jun 6, 2022 07:03AM
Jun 6, 2022 07:00AM Adicet Bio Reports Emerging Data from ADI-001 Phase 1 Trial at the American Society of Clinical Oncology Annual Meeting
May 26, 2022 05:02PM
May 26, 2022 05:00PM
May 12, 2022 04:10PM
May 5, 2022 07:00AM
Apr 19, 2022 07:04AM
Apr 19, 2022 07:00AM
Mar 4, 2022 09:21AM Pre-Open Stock Movers 03/04: (SG) (FNKO) (GPS) Higher; (OCGN) (SWBI) (VZIO) Lower (more...)
Dec 6, 2021 07:23AM
Dec 6, 2021 07:00AM
Dec 6, 2021 07:00AM
Nov 29, 2021 07:00AM
Nov 29, 2021 07:00AM
Nov 12, 2021 07:11AM
Nov 12, 2021 07:00AM Adicet Presents Preclinical Data for ADI-002, a GPC3-Targeted Development Candidate for Solid Tumors, at the SITC Annual Meeting
Nov 12, 2021 07:00AM
Nov 10, 2021 04:01PM
Nov 10, 2021 04:01PM
Nov 4, 2021 09:00AM
Nov 4, 2021 09:00AM
Oct 26, 2021 03:00AM
Oct 12, 2021 04:12PM ACETO Corp (ACET) Promotes Blake Aftab to Chief Scientific Officer and Senior VP
Oct 12, 2021 04:10PM

251,531 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All